FDA Authorizes Marketing of Kabrita's Infant Formula in the U.S.

Kabrita USA, a division of Ausnutria, has announced that its Kabrita Goat Milk-Based Infant Formula (0-12 months) meets the U.S. Food and Drug Administration's (FDA) nutrition and safety requirements and is authorized to market in the U.S. Kabrita Goat Milk-Based Infant Formula is expected to be available in the U.S. later this year.

The FDA has authorized Kabrita Goat-Milk Based Infant Formula for long-term use in the U.S. Kabrita is available in 35 countries worldwide. Arriving later this year, the Infant Formula expands Kabrita's portfolio; its Toddler Formula has been available in the U.S. since 2014. A recent study comparing Kabrita Goat Milk-Based Infant Formula to cow milk formula and using breastfed newborns as a reference group found it was safe, well tolerated and resulted in similar growth in babies.